• Home
  • Study Details
Open

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

To investigate the feasibility of the referral and engagement process in fatigue mitigation intervention for cancer-related fatigue among adults with CLL or other forms of indolent lymphoma.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive

Visit Availability

  • Standard business hours (M-F, 8-5)
  • Visits can be combined with regular clinical appointments

Location

North Carolina

What will be asked of you

Once you have undergone baseline physical assessments and questionnaires, you will be referred to a nutritionist and a physical rehabilitation specialist for individual consultations. You will receive a personalized diet and exercise plan and complete weekly exercise journals to track your participation over the next three months. After 4 weeks of this plan, you will meet with the dietician and rehabilitation physicians to check your progress and answer a questionnaire. There is an optional visit approximately 4 to 8 weeks later to check your progress and answer questionnaires, and then a final follow-up visit approximately 3 months after your baseline visit where you will again answer questionnaires and perform physical tests and questionnaires to check physical health. There are also optional blood draws at your baseline assessment and 3 months follow up visit, you will be asked to sign a separate consent form if you choose to participate in this part of the study.

In-person visits:
6
Total length of participation:
4 months

Looking for Specific Volunteers

Able to participate:

  • Confirmed diagnosis of indolent lymphoma: CLL OR FL, MZL, LPL, Waldenstrӧm's Macroglobulinemia, or Cutaneous T Cell Lymphoma (CTCL
  • Subjects is willing and able to comply with study procedures based on the judgement of the investigator
  • Written informed consent obtained to participate in the study and HIPAA authorization for release of personal health information.

Not eligible if:

  • Other co-existing malignancy
  • Significant cognitive impairment as defined by Mini-Cog score 0-2 (out of 5) that would prevent understanding of assessments or interventions.
  • Unstable or serious illness (e.g., unstable cardiac arrhythmia, severe anemia/thrombocytopenia) that would prevent safe participation in an exercise regimen, per discretion of treating physician.
  • ndividuals who are not able to consume an oral diet, due to swallowing difficulties or other reasons, as this might interfere with the nutritional intervention.

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

Lineberger Comprehensive Cancer Center
NC Cancer Hospital (Basnight)
UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Christopher Jensen
LCCC - Clinical Trials

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Lymphoma)

IRB Number

24-2300

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research